Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer-Reference-Cited by-同舟云学术

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

Published:2016-08-23 Issue:8 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Cheuk Daniel KL¹,Sieswerda Elske²,van Dalen Elvira C²,Postma Aleida³,Kremer Leontien CM²

Affiliation:

1. The University of Hong Kong, Queen Mary Hospital; Department of Pediatrics and Adolescent Medicine; Pokfulam Road Hong Kong China

2. Emma Children's Hospital/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD

3. University Medical Center Groningen and University of Groningen, Beatrix Children's Hospital; Department of Paediatric Oncology; Postbus 30.000 Groningen Netherlands 9700 RB

Publisher

Wiley

Subject

Pharmacology (medical)

Reference74 articles.

1. Clinical analysis of Sodium phosphocreatine on cardiac toxicity induced by anthracycline antibiotics in acute leukemia children;Chen;Chinese Journal of Cancer Prevention and Treatment,2008

2. Optimal multivariate matching before randomization;Greevy;Biostatistics,2004

3. Randomization inference with imperfect compliance in the ACE-inhibitor after anthracycline randomized trial;Greevy;Journal of the American Statistical Association,2004

4. Challenges in conducting a pediatric longitudinal prevention study: lessons from the ACE-inhibitor after anthracycline trial;Silber;Progress in Pediatric Cardiology,2005

5. The role of afterload reduction in the prevention of late anthracycline cardiomyopathy;Silber;Pediatric Blood & Cancer,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines;Children;2024-07-22

2. Association of European Paediatric and Congenital Cardiology practical recommendations for surveillance and prevention of cardiac disease in childhood cancer survivors: the importance of physical activity and lifestyle changes From the Association of European Paediatric and Congenital Cardiology Working Group Sports Cardiology, Physical Activity and Prevention, Working Group Adult Congenital Heart Disease, Working Group Imaging and Working Group Heart Failure;Cardiology in the Young;2024-01-04

3. An evidence gap map of interventions for noncommunicable diseases and risk factors among children and adolescents;Nature Medicine;2024-01

4. Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children;Pharmaceutics;2023-11-30

5. Cardiovascular toxicity of the treatment of oncological diseases in children and adolescents;Monatsschrift Kinderheilkunde;2023-09-06